Laura Crossen - 27 Jun 2022 Form 3 Insider Report for BED BATH & BEYOND INC (BBBY)

Role
SVP, CHIEF ACCOUNTING OFFICER
Signature
/s/ Katherine Walden, Attorney-in-Fact
Issuer symbol
BBBY
Transactions as of
27 Jun 2022
Net transactions value
$0
Form type
3
Filing time
07 Jul 2022, 17:42:18 UTC
Next filing
13 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BBBY Common Stock, $.01 par value per share 9,672 27 Jun 2022 Direct
holding BBBY Common Stock, $.01 par value per share 555 27 Jun 2022 Direct F1
holding BBBY Common Stock, $.01 par value per share 937 27 Jun 2022 Direct F2
holding BBBY Common Stock, $.01 par value per share 644 27 Jun 2022 Direct F3
holding BBBY Common Stock, $.01 par value per share 1,378 27 Jun 2022 Direct F4
holding BBBY Common Stock, $.01 par value per share 5,587 27 Jun 2022 Direct F5
holding BBBY Common Stock, $.01 par value per share 6,698 27 Jun 2022 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BBBY Restricted Stock Units (RSUs) 27 Jun 2022 Common Stock 16,012 $0.000000 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock ("RSAs") awarded to the Reporting Person. The RSAs will vest on June 10, 2023, subject to the terms, conditions and restrictions of the award agreement governing the grant.
F2 Represents a grant of RSAs awarded to the Reporting Person. The RSAs are scheduled to vest as follows: 468 RSAs will vest on June 12, 2023; and 469 RSAs will vest on June 12, 2024, subject to the terms, conditions and restrictions of the award agreement governing the grant.
F3 Represents a grant of RSAs awarded to the Reporting Person. The RSAs are scheduled to vest as follows: 214 RSAs will vest on June 11, 2023; 215 RSAs will vest on June 11, 2024; and 215 RSAs will vest on June 11, 2025, subject to the terms, conditions and restrictions of the award agreement governing the grant.
F4 Represents a grant of RSAs awarded to the Reporting Person. The RSAs are scheduled to vest as follows: 344 RSAs will vest on June 10, 2023; 345 RSAs on June 10, 2024; 344 RSAs on June 10, 2025; and 345 RSAs on June 10, 2026 subject to the terms, conditions and restrictions of the award agreement governing the grant.
F5 Represents a grant of restricted stock units ("RSUs") awarded to the Reporting Person. The RSUs are scheduled to vest as follows: 2,793 RSUs will vest on October 14, 2022; and 2,794 RSUs will vest on October 14, 2023, subject to the terms, conditions and restrictions of the award agreement governing the grant.
F6 Represents a grant of RSUs awarded to the Reporting Person. 3,349 RSUs are scheduled to vest on May 10th of each of 2023 and 2024, subject to the terms, conditions and restrictions of the award agreement governing the grant.
F7 Each RSU represents a contingent right to receive the cash value of one share of Issuer common stock upon vesting.
F8 Represents a grant of RSUs awarded to the Reporting Person. The RSUs are scheduled to vest as follows: 5,337 RSUs will vest on May 10, 2023; 5,338 RSUs will vest on May 10, 2024; and 5,337 RSUs will vest on May 10, 2025, subject to the terms, conditions and restrictions of the award agreement governing the grant.

Remarks:

Exhibit 24 - Power of Attorney